Literature DB >> 20730006

Migraine accompagnée after transseptal puncture.

L Jordaens1, P Janse, T Szili-Torok, Y Van Belle.   

Abstract

Migraine has never been reported as a complication of transseptal puncture for ablation of atrial fibrillation. We studied its incidence before and after such procedures after observing some striking new migraine in several patients. A total of 8% of procedures for pulmonary vein isolation with a 15 Fr sheath used for transseptal puncture were associated with new headache with ocular symptoms or migraine within three months. Exacerbation of pre-existing migraine was reported in another 7% of procedures. More complaints were seen in redo procedures. The questionnaires were performed at three months after the intervention and there was no more evidence of persisting flow over the atrial septum at that time, when most complaints had already disappeared. This has important implications for follow-up after ablation for atrial fibrillation. (Neth Heart J 2010;18:374-5.).

Entities:  

Keywords:  Atrial Fibrillation; Catheter Ablation; Heart Septum; Migraine Disorders; Punctures

Year:  2010        PMID: 20730006      PMCID: PMC2922785          DOI: 10.1007/BF03091795

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  7 in total

Review 1.  In the clinic. Migraine.

Authors:  Jennifer F Wilson
Journal:  Ann Intern Med       Date:  2007-11-06       Impact factor: 25.391

2.  Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

Authors:  Riccardo Cappato; Hugh Calkins; Shih-Ann Chen; Wyn Davies; Yoshito Iesaka; Jonathan Kalman; You-Ho Kim; George Klein; Douglas Packer; Allan Skanes
Journal:  Circulation       Date:  2005-02-21       Impact factor: 29.690

3.  Migraine with aura following atrial septostomy for pulmonary arterial hypertension.

Authors:  Mark P Rogan; Kevin P Walsh; Sean P Gaine
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2007-01

4.  Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.

Authors:  Stephan Windecker; Andreas Wahl; Krassen Nedeltchev; Marcel Arnold; Markus Schwerzmann; Christian Seiler; Heinrich P Mattle; Bernhard Meier
Journal:  J Am Coll Cardiol       Date:  2004-08-18       Impact factor: 24.094

5.  A self-administered screener for migraine in primary care: The ID Migraine validation study.

Authors:  R B Lipton; D Dodick; R Sadovsky; K Kolodner; J Endicott; J Hettiarachchi; W Harrison
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

6.  Pulmonary vein isolation using an occluding cryoballoon for circumferential ablation: feasibility, complications, and short-term outcome.

Authors:  Yves Van Belle; Petter Janse; Maximo J Rivero-Ayerza; Andrew S Thornton; Emile R Jessurun; Dominic Theuns; Luc Jordaens
Journal:  Eur Heart J       Date:  2007-06-14       Impact factor: 29.983

7.  Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache.

Authors:  Andrew Dowson; Michael J Mullen; Richard Peatfield; Keith Muir; Arif Anis Khan; Christopher Wells; Susan L Lipscombe; Trevor Rees; Joseph V De Giovanni; W Lindsay Morrison; David Hildick-Smith; Giles Elrington; W Stewart Hillis; Iqbal S Malik; Anthony Rickards
Journal:  Circulation       Date:  2008-03-03       Impact factor: 29.690

  7 in total
  1 in total

1.  New migraine with visual disturbance after cryoballoon ablation of atrial fibrillation.

Authors:  Annupreet Nadha; Eric S Williams
Journal:  J Atr Fibrillation       Date:  2017-10-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.